COMIRNATY ORIGINAL & OMICRON BA.4/BA.5

Approval Id: 2a007a42998776ec
Drug Approval Canada Name: COMIRNATY ORIGINAL & OMICRON BA.4/BA.5
Product Name: COMIRNATY ORIGINAL & OMICRON BA.4/BA.5
Status: Cancelled Post Market
Status Date: 2024-05-03
Original Market Date: 2022-10-11
Din: 02531461
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BN01 COVID-19, RNA-BASED VACCINE
Atc Name: j 07 bn 01
Aig Number: 0264101001
Company Name: BioNTech Manufacturing GmbH
Company Address: An Der Goldgrube 12, Mainz, Rheinland-Pfalz, Germany, 55131
Company Detail Path: /organization/biontech-manufacturing-gmbh

FAMTOZINAMERAN

15 MCG / 0.3 ML

TOZINAMERAN

15 MCG / 0.3 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2a007a42998776ec

Type

Standard